City of Hope, a comprehensive cancer research and treatment center in Duarte, California, has announced a $2.5 million grant from the Marcus Foundation to test an innovative treatment for brain tumors and lymphomas.
The grant will help fund human clinical trials of a therapy developed by Cancer Immunotherapeutics Program co-leader Hua Eleanor Yu and her colleagues that simultaneously dismantles the tumors' support network while stimulating the immune system to attack the cancerous cells. Scheduled to begin in October 2014, the trials will assess the therapy's effectiveness against glioblastoma multiforme, an aggressive type of brain tumor, and subtypes of B-cell lymphoma, both of which are difficult to treat with standard therapy.
"This vital grant from the Marcus Foundation will enable us to turn promising study results into potentially lifesaving treatments for the thousands facing brain tumors and lymphomas," said City of Hope CEO Michael A. Friedman. "With fewer public resources available for research due to stagnant government funding and the impact of sequestration, this philanthropic support will allow us to push forward with innovative ideas that could become tomorrow's cures."